###begin article-title 0
Transcription Factor SP4 Is a Susceptibility Gene for Bipolar Disorder
###end article-title 0
###begin p 1
Conceived and designed the experiments: XZ MAG JK. Performed the experiments: XZ WT SG. Analyzed the data: XZ WT TAG LH MAG JK. Contributed reagents/materials/analysis tools: TAG. Wrote the paper: XZ TAG LH MAG JK.
###end p 1
###begin p 2
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1589 1592 1589 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
###xml 242 247 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 1425 1430 <span type="species:ncbi:10090">mouse</span>
###xml 1605 1609 <span type="species:ncbi:10090">mice</span>
###xml 1707 1712 <span type="species:ncbi:9606">human</span>
###xml 1725 1730 <span type="species:ncbi:10090">mouse</span>
The Sp4 transcription factor plays a critical role for both development and function of mouse hippocampus. Reduced expression of the mouse Sp4 gene results in a variety of behavioral abnormalities relevant to human psychiatric disorders. The human SP4 gene is therefore examined for its association with both bipolar disorder and schizophrenia in European Caucasian and Chinese populations respectively. Out of ten SNPs selected from human SP4 genomic locus, four displayed significant association with bipolar disorder in European Caucasian families (rs12668354, p = 0.022; rs12673091, p = 0.0005; rs3735440, p = 0.019; rs11974306, p = 0.018). To replicate the genetic association, the same set of SNPs was examined in a Chinese bipolar case control sample. Four SNPs displayed significant association (rs40245, p = 0.009; rs12673091, p = 0.002; rs1018954, p = 0.001; rs3735440, p = 0.029), and two of them (rs12673091, rs3735440) were shared with positive SNPs from European Caucasian families. Considering the genetic overlap between bipolar disorder and schizophrenia, we extended our studies in Chinese trios families for schizophrenia. The SNP7 (rs12673091, p = 0.012) also displayed a significant association. The SNP7 (rs12673091) was therefore significantly associated in all three samples, and shared the same susceptibility allele (A) across all three samples. On the other hand, we found a gene dosage effect for mouse Sp4 gene in the modulation of sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder. The deficient sensorimotor gating in Sp4 hypomorphic mice was partially reversed by the administration of dopamine D2 antagonist or mood stabilizers. Both human genetic and mouse pharmacogenetic studies support Sp4 gene as a susceptibility gene for bipolar disorder or schizophrenia. The studies on the role of Sp4 gene in hippocampal development may provide novel insights for the contribution of hippocampal abnormalities in these psychiatric disorders.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 241 244 241 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Heisler1">[1]</xref>
###xml 348 356 348 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 356 359 356 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Suske1">[2]</xref>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp1</italic>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 485 488 485 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Supp1">[3]</xref>
###xml 490 493 490 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou1">[4]</xref>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 711 714 711 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 732 735 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou2">[5]</xref>
###xml 759 762 759 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 806 809 806 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1016 1019 1016 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou1">[4]</xref>
###xml 1021 1024 1021 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Braff1">[6]</xref>
###xml 1026 1029 1026 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Geyer1">[7]</xref>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
The Sp4 gene, a member of Sp1 family of transcription factors, recognizes GC-rich elements in the promoter of a variety of genes. These GC-rich sequences are readily identified in the "CpG islands" around the promoters of a variety of genes [1]. Both Sp1 and Sp4 recognize the same DNA binding sequence, and functionally substitute with each other in vitro[2]. In contrast to the ubiquitous expression pattern of the Sp1 gene, the Sp4 gene is restrictively expressed in nervous system [3], [4]. Our previous studies demonstrated that the complete absence of the Sp4 gene impaired postnatal development of hippocampal dentate gyrus by reducing cell proliferation, dendritic growth, and dendritic arborization in Sp4 null mutant mice [5]. Moreover, hypomorphic Sp4 mutant mice with reduced expression of the Sp4 gene displayed vacuolization in the hippocampus as well as deficits in sensorimotor gating and memory, putative endophenotypes for several psychiatric disorders including schizophrenia and bipolar disorder [4], [6], [7].
###end p 4
###begin p 5
###xml 194 197 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Fallin1">[8]</xref>
###xml 199 202 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Lerer1">[9]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Moskvina1">[10]</xref>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Crowe1">[11]</xref>
###xml 231 235 231 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Knowles1">[12]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Bakker1">[13]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Risch1">[14]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Wolpert1">[15]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Ingram1">[16]</xref>
###xml 273 277 273 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Folstein1">[17]</xref>
###xml 300 304 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-DeteraWadleigh1">[18]</xref>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Curtis1">[19]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-LeNiculescu1">[20]</xref>
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-DeteraWadleigh1">[18]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Nurnberger1">[21]</xref>
###xml 654 658 654 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Curtis1">[19]</xref>
###xml 1615 1618 1615 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
###xml 1019 1024 <span type="species:ncbi:9606">human</span>
###xml 1122 1127 <span type="species:ncbi:9606">human</span>
###xml 1264 1269 <span type="species:ncbi:9606">human</span>
###xml 1609 1614 <span type="species:ncbi:10090">mouse</span>
On the other hand, the human SP4 gene has been mapped to chromosome 7p15, where a susceptibility locus was suggested for a broad spectrum of human psychiatric disorders, including schizophrenia [8], [9], [10], panic disorder [11], [12], ADHD [13], autism [14], [15], [16], [17], and bipolar disorder [18], [19], [20]. Of these genome linkage studies, we were particularly interested in the finding that one locus on chromosome 7, at the marker D7S1802, was found to associate with bipolar disorder, which is about 700 kb away from the SP4 gene [18], [21]. Another genome scan also suggested a susceptibility locus for bipolar disorder on chromosome 7p15 [19]. All these psychiatric disorders displayed sensorimotor gating deficit (18). We therefore hypothesized that a susceptibility gene may contribute to the pathogenesis of these different clinical disorders by modulating sensorimotor gating, an endophenotype for several psychiatric disorders. Considering deficient sensorimotor gating in Sp4 hypomorphic mice and human SP4 gene localized in a susceptibility locus for bipolar disorder, we therefore examined whether human SP4 gene may associate with bipolar disorder and schizophrenia. We selected ten single nucleotide polymorphisms (SNPs) encompassing the human SP4 genomic locus, and examined their association with both bipolar disorder and schizophrenia in European and Chinese Han populations, respectively. Significant associations were observed between SP4 gene and bipolar disorder/schizophrenia in all three independent samples. Interestingly, our further studies found that the expression of mouse Sp4 gene exhibits haploinsufficiency for modulating sensorimotor gating. Moreover, administration of either dopamine D2 antagonists or mood stabilizers can partially reverse the sensorimotor gating deficits.
###end p 5
###begin title 6
Materials and Methods
###end title 6
###begin title 7
UCSD and NIMH families with bipolar disorder
###end title 7
###begin p 8
###xml 646 650 646 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Nurnberger2">[22]</xref>
###xml 826 830 826 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Kelsoe1">[23]</xref>
The total sample for analysis included 1872 individuals from 427 Caucasian families, approximately half of which consisted of both parents and one affected offspring with the remaining consisting of both parents and two or more affected offspring. The average family consisted of 4.4 individuals in 2 generations. The families chosen for this study derived from several sources. The National Institute of Mental Health Genetics Initiative for Bipolar Disorder waves 1-4 pedigree collections were collected as part of a consortium and ascertained through a bipolar I proband, and assessed using the Diagnostic Interview for Genetic Studies (DIGS) [22]. Families were also drawn from the University California San Diego consortium including collection sites at UCSD, University of British Columbia, and University of Cincinnati [23]. These families were ascertained through a bipolar I or bipolar II proband and selected for the presence of at least two other mood disordered family members. The Structured Clinical Interview for DSM-III-R (SCID) was used to directly interview subjects for this sample. For each collection, information from the interview, other family informants, and medical records were then reviewed by a panel of clinicians in order to make a final best-estimate diagnosis. DNA of all study subjects was prepared from cultured lymphoblastoid cells.
###end p 8
###begin title 9
Chinese bipolar cases and control sample
###end title 9
###begin p 10
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 316 324 <span type="species:ncbi:9606">patients</span>
###xml 361 369 <span type="species:ncbi:9606">patients</span>
506 unrelated bipolar patients (male: 284, female: 222; average of age: 37.8+/-11.4 years; average age of onset: 26.7+/-10.6 years) and 507 unrelated controls (male: 287, female: 220; age: 36.4+/-8.7 years) were recruited for the study. All the subjects were of Han origin from Anhui province. Among the 506 bipolar patients diagnosed using DSM-IV, 419 (82.8%) patients were type I Bipolar. Final diagnosis was made with two independent psychiatrists on the basis of interview and medical records. All participating subjects provided written informed consent according to procedures approved by the Ethic Committee of Bio-X Center, Shanghai Jiao Tong University.
###end p 10
###begin title 11
Chinese trio families with schizophrenia
###end title 11
###begin p 12
A total of 325 trio families were collected from several different sites with 126 families from Shanghai, 71 families from Shanxi province, 86 families from Jilin province, and 42 families from Changchun. All subjects were Han Chinese in origin. There were 145 female and 163 male probands with an average age of 24.0+/-6.6. Clinical diagnoses were made according to DSM-IV, and ascertained by an independent clinician. All the subjects provided written informed consent according to procedures approved by the Ethic Committee of Bio-X Center, Shanghai Jiao Tong University.
###end p 12
###begin title 13
Genotyping
###end title 13
###begin p 14
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 425 430 <span type="species:ncbi:9606">human</span>
Human SP4 gene encompasses about 90 kb on chromosome 7p15. To conduct a comprehensive association study on Sp4 gene with bipolar disorder in European Caucasian families, we selected ten SNPs which started from the site 5 kb upstream of human SP4 transcription start site and ended at the site 3 kb downstream of its transcription termination. The ten SNPs have good heterozygosity and are representative for LD structures of human SP4 gene in European Caucasian population according to HapMap data. The same set of SNPs was used for replication studies in Chinese bipolar case control sample. A subset of 5 of these SNPs with MAFs >0.10 were genotyped in the Chinese schizophrenia trio families. The primer pairs for the genotyping of individual SNPs were ordered from Applied Biosystems. All SNPs were genotyped in Caucasian and Chinese samples using the TaqMan allele specific assay method (Applied Biosystems) according to the manufacturer's protocols. Concentrations and cycling parameters were optimized to produce clusters of values for heterozygotes and homozygotes separated by >4 standard deviations. The allele frequency of SNP7 (rs12673091) was also confirmed by directly sequencing in Chinese case control sample for bipolar disorder.
###end p 14
###begin title 15
Genetic association analysis
###end title 15
###begin p 16
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Barrett1">[24]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Halperin1">[25]</xref>
###xml 740 744 740 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Halperin1">[25]</xref>
###xml 1665 1669 1663 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Barrett1">[24]</xref>
###xml 1986 1990 1984 1988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Purcell1">[26]</xref>
###xml 2198 2202 2196 2200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Dudbridge1">[27]</xref>
In the Caucasian sample, Haploview v.4.0 [24] was used for an assessment of linkage disequilibrium (LD) within the gene, as well as calculations of allele frequencies and Hardy-Weinberg Equilibrium (HWE), based on unrelated individuals in all samples. The program HAP [25] was used for an evaluation of the block structure of SP4 in the Caucasian bipolar family sample, and the resulting structure was used to inform subsequent haplotype analyses. Haplotypes for unrelated individuals (i.e., parents) in the sample were determined using the imperfect phylogeny phasing method implemented in HAP. Following phasing, HAP partitioned the region into haplotype blocks of correlated SNPs using an algorithm that minimizes the number of tag SNPs [25]. Following block and haplotype identification, the phylogenetic relationships between haplotypes were computed by optimizing a probabilistic model that assumes exponential population growth after a population bottleneck. Under this assumption, any variants after the bottleneck occur in haplotypes that are also present in the modern population. Haplotypes that have no intermediates between them (i.e., that vary by >/=2 SNPs) are assumed to be before the bottleneck and are therefore "ancestral" haplotypes. "Common" haplotypes are defined as being a single mutation or recombination event away from the ancestral haplotypes as such events are likely to have happened after a major population bottleneck. The algorithm identifies "recent" haplotypes by considering rare (<5%) haplotypes and explaining them with either a single gene conversion, mutation, or recombination event from the "common" haplotypes. Haploview [24] was then used to perform the parenTDT test using single SNPs and haplotypes. In addition to providing protection against population stratification, the parenTDT can also add considerable power to family-based association analyses if the parents are measured on the phenotype, as most of ours are, and are discordant [26]. For the haplotype analyses, counts were obtained by summing the fractional likelihoods of each individual for each haplotype. Permutations tests were performed to correct for multiple comparisons. UNPHASED [27] was used for genotypic association analyses. All association analyses were performed under a definition of bipolar disorder that included bipolar I and II, as well as schizoaffective disorder, bipolar-type.
###end p 16
###begin p 17
###xml 16 20 16 20 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Barrett1">[24]</xref>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Wang1">[28]</xref>
Haploview v.4.0 [24] was used to calculate allele frequencies, Hardy-Weinberg Equilibrium (HWE), and p value of both single SNPs and haplotypes in Chinese BP case control samples. The LD block structure was calculated using the four gamete rule, a variant on the algorithm described by Wang et al [28]. For each marker pair, the population frequencies of the 4 possible two-marker haplotypes were computed. If all 4 are observed with at least frequency 0.01, a recombination is deemed to have taken place. Blocks are formed by consecutive markers where only 3 gametes are observed. The 1% cutoff can be edited to make the definition more or less stringent.
###end p 17
###begin p 18
###xml 192 196 192 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Dudbridge2">[29]</xref>
The family-based association analyses of the single SNPs and haplotypes in the Chinese schizophrenia trio families were performed using the TDTPHASE module implemented in the UNPHASED program [29]. An E-M algorithm was used to estimate missing genotypes and excessively rare haplotypes were removed from the analyses.
###end p 18
###begin title 19
###xml 16 20 <span type="species:ncbi:10090">mice</span>
Sp4 hypomorphic mice
###end title 19
###begin p 20
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 53 56 53 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou1">[4]</xref>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou1">[4]</xref>
###xml 552 562 552 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 359 364 <span type="species:ncbi:10090">mouse</span>
###xml 405 409 <span type="species:ncbi:10090">Mice</span>
###xml 741 745 <span type="species:ncbi:10090">Mice</span>
The Sp4 hypomorphic mice were generated as described [4], and maintained in both S129 and Black Swiss, respectively. The Sp4 test cohort was generated by breeding the heterozygous Sp4 mice between the two genetic backgrounds. Therefore, all the test mice will have the same genetic mixed S129/Black Swiss background as the F1 generation. PCR was used for Sp4 mouse genotyping as previously described [4]. Mice were housed in a climate-controlled animal colony with a reversed day/night cycle. Food (Harlan Teklab, Madison, WI) and water were available ad libitum, except during behavioral testing. All behavioral testing procedures were approved by the UCSD institutional animal care and use committee prior to the onset of the experiments. Mice were maintained in American Association for Accreditation of Laboratory Animal Care approved animal facilities at the local VA Hospital. This facility meets all Federal and State requirements for animal care.
###end p 20
###begin title 21
Prepulse inhibition session
###end title 21
###begin p 22
Startle reactivity was measured using eight startle chambers (SR-LAB, San Diego Instruments, San Diego, CA) with background noise of 65 dB and the various acoustic stimuli. All PPI test sessions consisted of startle trials (PULSE-ALONE), prepulse trials (PREPULSE+PULSE), and no-stimulus trials (NOSTIM). The PULSE-ALONE trial consisted of a 40-ms 120-dB pulse of broad-band noise. PREPULSE+PULSE trials consisted of a 20-ms noise prepulse, 80 ms delay, then a 40-ms 120-dB startle pulse (100 ms onset to onset). The acoustic prepulse intensities were 69, 73, and 81 dB (ie 4, 8, and 16 dB above the 65-dB background noise). The NOSTIM trial consisted of background noise only. The test session began and ended with five presentations of the PULSE-ALONE trial; in between, each acoustic or NOSTIM trial type was presented 10 times in a pseudo-random order. There was an average of 15 s (range: 12-30 s) between trials. A background noise level of 65 dB was presented for a 10-min acclimation period and continued throughout the test session.
###end p 22
###begin title 23
Drugs
###end title 23
###begin p 24
Raclopride (3 mg/kg, Sigma, St. Louis, MO, USA) was dissolved in distilled water and injected intraperitoneally at a volume of 5 ml/kg 10 min before the start of the test session. Lithium chloride anhydrous (85 mg/kg, Sigma-Aldrich) was dissolved in saline and administered i.p. at a volume of 5 ml/kg 60 min before the start of the test session. The sodium salt of valproate (100 mg/kg, Sigma-Aldrich) was dissolved in saline and administered i.p. at a volume of 5 ml/kg 10 min before the start of the test session. Carbamazepine (25 mg/kg, Sigma-Aldrich) was suspended in saline containing 5% Tween 80 and maintained at 60degreesC in the dark, and administered i.p. at a volume of 10 ml/kg 40 min before the start of the test session.
###end p 24
###begin title 25
Data Analysis
###end title 25
###begin p 26
The amount of PPI was calculated as a percentage score for each acoustic prepulse trial type: % PPI = 100-{[(startle response for PREPULSE+PULSE)/(startle response for PULSE-ALONE)]x100}. For statistical analyses, repeated measures analysis of variance (ANOVA) with genotype as a between subject factor and drug treatment, block and prepulse intensity as within subjects factors was performed on the %PPI data. The same analysis was also performed on the acoustic startle data (PULSE alone trials). Where appropriate, post hoc analyses were carried out using Newman-Keuls or Tukey's test. Alpha level was set to 0.05. All statistical analyses were carried out using the BMDP statistical software (Statistical Solutions Inc., Saugus, MA).
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
European Caucasian Families for Bipolar Disorder
###end title 28
###begin p 29
###xml 132 140 132 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g001">Figure 1</xref>
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Halperin1">[25]</xref>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Barrett1">[24]</xref>
###xml 22 27 <span type="species:ncbi:9606">human</span>
Ten SNPs spanning the human SP4 locus were selected from both public (Genome Browser, UCSC) and proprietary (Celera) SNP databases (Figure 1). Following genotyping, HAP [25] was used for an evaluation of the block structure of SP4, and Haploview [24] was used for an assessment of linkage disequilibrium (LD) and association. None of the ten SNPs were found to deviate from HWE (p>0.05) in this sample, and all were quite common with minor allele frequencies (MAFs) >0.20.
###end p 29
###begin title 30
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human SP4 genomic structure.
###end title 30
###begin p 31
###xml 54 59 <span type="species:ncbi:9606">human</span>
Ten SNPs were selected from the site 5 kb upstream of human SP4 transcription start site and to the site 3 kb downstream of its transcription termination. All ten SNPs have good heterozygosity in European Caucasian population according to HapMap data.
###end p 31
###begin p 32
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005196-t001">Table 1</xref>
###xml 790 795 <span type="species:ncbi:9606">human</span>
Table 1 describes the results of the single-SNP association analyses using the parenTDT test. SNP 7 (rs12673091) showed the most significant association in the allelewise analyses with a p value of 0.0005 (permutation p = 0.0007) and an overtransmission of the major ("A") allele. This SNP also revealed a genotypic effect with an overall p value of 0.009. The p values for the A/A and A/G genotypes were 0.004 and 0.031, respectively, consistent with the significant overtransmission of the "A" allele in the allelewise analyses. Three other SNPs (SNP 6, 9, and 10) were nominally significant, possibly due to their correlations with SNP 7. Interestingly, one of these SNPs, SNP 9 (rs3735440), is located within a potential microRNA (miR-145) binding site in the 3' untranslated region of human SP4 gene, and displayed nominally significant (p = 0.019) overtransmission of the "C" allele.
###end p 32
###begin title 33
Association analysis of SP4 gene with both bipolar disorder and schizophrenia.
###end title 33
###begin p 34
Alleles for each SNP are presented as major/minor, respectively.
###end p 34
###begin p 35
Key: MAF = minor allele frequency; Risk = risk allele; T:U = transmitted to untransmitted ratio.
###end p 35
###begin p 36
###xml 223 232 223 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g002">Figure 2a</xref>
###xml 388 395 388 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005196-t002">Table 2</xref>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g002">Figure 2b</xref>
An assessment of LD across the SP4 gene revealed three LD blocks with a high degree of LD observed between SNPs 6-10, all of which derive from block 3 and four of which displayed at least marginal evidence for association (Figure 2a). We therefore performed haplotypic association analyses on all haplotypes from block 3 with frequencies >0.01. The results of these analyses are shown in Table 2. The global p value was 0.004 with one haplotype (AGTTA) in particular revealing a significant undertransmission and a p value of 0.0004 (permutation p = 0.001). This haplotype contains the "G" allele of SNP 7, which was the previously undertransmitted allele in the single SNP analyses. Another haplotype (CATCT) containing the previously overtransmitted "A" allele was marginally significant as well. Phylogenic analyses of haplotypes composed of all ten SNPs, as shown in Figure 2b, reveal that this overtransmitted block 3 haplotype derives from two related ancestral haplotypes (haplotypes BO and BP) that form a haplotype cluster of several related common haplotypes. On the other hand, the significantly undertransmitted block 3 haplotype (AGTTA) comprises a rather distinct ancestral haplotype (haplotype A) that is relatively common but for which there are only a few relatively rare recent haplotype derivatives. Common haplotypes derived from the other ancestral haplotype (haplotype BN) did not show an association with bipolar disorder.
###end p 36
###begin title 37
###xml 18 23 <span type="species:ncbi:9606">human</span>
The LD pattern of human SP4 gene.
###end title 37
###begin p 38
###xml 822 829 822 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Methods</xref>
(a) Detailed LD structure of SP4 gene in the UCSD/NIMH sample, along with the designation of the three haplotype blocks, the haplotypes within, and the relationships of haplotypes between blocks. Measures of the strengths of the LD are indicated within each block, which are color-coded with red being high LD and white being low LD. An (*) indicates a tagging SNP. Heavy solid lines indicate a frequency >0.10, whereas solid lines indicate a frequency >0.01. The frequencies of each haplotype are indicated to the right. (b) Predicted phylogeny of the SP4 gene. Solid lines indicate single mutation events in a lineage, and dashed lines indicate recombination events in a lineage (there are necessarily two sources for each resulting daughter haplotype). "Ancestral", "common," and "recent" haplotypes are defined in the Methods section. A "?" in an ancestral haplotype represents the precursor to a mutation, which allows for the presentation of the information that the two haplotypes are related, knowing where the mutation occurred but not which haplotype is the parent. (c) Details of the LD and haplotype structure of the SP4 gene in the Chinese BPAD case-control sample.
###end p 38
###begin title 39
Haplotype analyses of SP4 association in bipolar samples.
###end title 39
###begin p 40
Global p = 0.004.
###end p 40
###begin title 41
Chinese Case-Control Sample for Bipolar Disorder
###end title 41
###begin p 42
###xml 798 805 798 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005196-t001">Table 1</xref>
To provide a replication of these results, the same ten SNPs were genotyped in a sample of 506 Chinese bipolar cases and 507 controls. SNP10 (rs11974306) was found to deviate from HWE in this sample and thus removed from further analyses. These SNPs were generally more rare in the Chinese population with only five of the ten SNPs displaying MAFs >0.10, suggesting population differences between individuals of Caucasian and Chinese ancestry for this gene. Four SNPs differed significantly between cases and controls. SNP7 (rs12673091) displayed a significant association in the Chinese bipolar case-control sample with an overtransmission of the minor ("A") allele s (p value, 0.002; permutation p value 0.014), thereby replicating the results of our analyses in the Caucasian family sample (see Table 1). Moreover, SNP9 (rs3735440) displayed a moderately significant association (p = 0.029) with an overtransmission of the "C" allele in Chinese population, also replicating our results in the Caucasian family analyses.
###end p 42
###begin p 43
###xml 106 115 106 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g002">Figure 2c</xref>
###xml 544 551 544 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005196-t002">Table 2</xref>
Similar to the Caucasian sample, a high degree of LD between SNPs 6-9 was observed in the Chinese sample (Figure 2c). Since three of the four SNPs significantly associated with bipolar disorder in this sample all lie within this LD block (block 3), we performed association analyses of all haplotypes composed of these three SNPs. Two haplotypes CATC (p = 0.027) and AGTT (p = 0.04) displayed significant overtransmission and undertransmission, respectively, in this sample, consistent with the observed associations in the Caucasian families (Table 2).
###end p 43
###begin title 44
Chinese Trio Families for Schizophrenia
###end title 44
###begin p 45
###xml 433 440 433 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005196-t001">Table 1</xref>
It has been suggested that both bipolar disorder and schizophrenia share common genetic risk factors. To explore whether SP4 gene might also be associated with schizophrenia, we conducted genetic studies on a sample of 325 Chinese trio families with schizophrenia. We observed an association between SNP7 (rs12673091) and schizophrenia in the Chinese population (p = 0.012) with a significant overtransmission of the "A" allele (see Table 1). These results are thus consistent with those for SNP7 in both the Caucasian and Chinese bipolar samples.
###end p 45
###begin p 46
###xml 695 698 695 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Suske1">[2]</xref>
###xml 811 815 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-BenShachar1">[30]</xref>
###xml 1030 1033 1030 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 207 212 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 538 543 <span type="species:ncbi:9606">human</span>
###xml 592 597 <span type="species:ncbi:9606">human</span>
###xml 802 810 <span type="species:ncbi:9606">patients</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
All together, we observed a significant genetic association between human SP4 gene and bipolar disorder and schizophrenia in all three independent samples. To correlate these positive SNPs with the level of human SP4 gene expression, we extracted total RNA from the lymphoblastoid cells of European Caucasian samples. Unfortunately, we could not detect the expression of human SP4 gene by RT-PCR. The neuronal restrictive expression of SP4 gene prevented our further effort to investigate the effects of the positive SNPs on the level of human SP4 gene expression. However, the expression of human SP1 gene, which functionally substitutes with SP4 gene by recognizing the same DNA binding motif [2] , was found to be reduced in both prefrontal cortex and striatum of postmortem brains of schizophrenia patients [30]. Therefore, reduced expression of SP1 family transcription factors may play an important role in pathophysiology of schizophrenia and related disorders. Consistent with this notion, mice with reduced expression of Sp4 gene displayed deficient sensorimotor gating and memory.
###end p 46
###begin title 47
###xml 23 28 <span type="species:ncbi:10090">Mouse</span>
Haploinsufficiency for Mouse Sp4 Gene in Modulating Sensorimotor Gating
###end title 47
###begin p 48
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Braff1">[6]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Perry1">[31]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Giakoumaki1">[32]</xref>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Geyer1">[7]</xref>
###xml 234 237 234 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 426 429 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou1">[4]</xref>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 576 579 576 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 684 687 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 739 748 739 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g003">Figure 3a</xref>
###xml 751 759 751 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Post hoc</italic>
###xml 859 862 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 923 926 923 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1001 1004 1001 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1262 1271 1262 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g003">Figure 3b</xref>
###xml 128 133 <span type="species:ncbi:9606">human</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
###xml 1005 1009 <span type="species:ncbi:10090">mice</span>
###xml 1152 1156 <span type="species:ncbi:10090">mice</span>
###xml 1293 1297 <span type="species:ncbi:10090">mice</span>
###xml 1351 1355 <span type="species:ncbi:10090">mice</span>
Sensorimotor gating, a putative endophenotype for both schizophrenia and bipolar disorder, has been studied extensively in both human patients and animal models [6], [31], [32], [7]. Our previous studies demonstrated that hypomorphic Sp4 mutant mice, in which expression of the Sp4 gene is reduced to 2%-5% of the level in wildtype mice, displayed a variety of behavioral abnormalities including deficient sensorimotor gating [4]. To further examine whether the level of Sp4 gene expression has dosage effects on sensorimotor gating, we conducted prepulse inhibition tests on Sp4 heterozygous mice as well as their sibling wildtype and homozygous mutant mice. There was a significant Sp4 gene effect on PPI with p value less than 0.00001 (Figure 3a). Post hoc analysis revealed that there were significant differences in PPI between wildtype and heterozygous Sp4 mice at all three different prepulse levels. The homozygous Sp4 mutants also displayed significantly reduced PPI relative to heterozygous Sp4 mice which in turn have less PPI than wildtype siblings, consistent with a gene-dosage effect. No gender effect was observed in the PPI tests. All mice displayed normal startle habituation, with no difference among different genotypes in startle magnitude (Figure 3b). Nevertheless, male mice tend to have higher magnitude of startle than female mice, presumably due to their heavier body weight.
###end p 48
###begin title 49
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Haploinsufficiency of mouse Sp4 gene in the modulation of prepulse inhibition.
###end title 49
###begin p 50
###xml 14 18 <span type="species:ncbi:10090">mice</span>
The number of mice for the PPI studies were included in the parentheses after individual genotype (a) Prepulse inhibition at three different prepulse levels. (b) Startle habituation within the PPI session. * p<0.05; ** p<0.01.
###end p 50
###begin title 51
Improvement of PPI Deficit with Dopamine D2 Antagonist and Mood Stabilizers
###end title 51
###begin p 52
###xml 171 172 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Geyer1">[7]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Geyer2">[33]</xref>
###xml 434 438 434 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Meincke1">[34]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Swerdlow1">[35]</xref>
###xml 486 489 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1060 1068 1060 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Post hoc</italic>
###xml 1252 1255 1252 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1290 1299 1290 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g004">Figure 4a</xref>
###xml 1418 1419 1418 1419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1472 1476 1472 1476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Stamford1">[36]</xref>
###xml 1478 1482 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Kita1">[37]</xref>
###xml 1521 1524 1521 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1632 1633 1632 1633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 197 202 <span type="species:ncbi:9606">human</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 1284 1288 <span type="species:ncbi:10090">mice</span>
###xml 1375 1379 <span type="species:ncbi:10090">mice</span>
###xml 1553 1557 <span type="species:ncbi:10090">mice</span>
The importance of dopamine neurotransmission for the pathogenesis of both bipolar disorder and schizophrenia has been suggested by both the clinical efficacy of dopamine D2 receptor antagonists in human patients and their central roles in modulating relevant behaviors in animal models. As in rodent models of deficient PPI [7], [33], the administration of antipsychotics significantly improved PPI deficits in schizophrenia patients [34], [35]. To examine whether PPI deficits in both Sp4 heterozygous and homozygous mutant mice can be improved by administration of dopamine D2 receptor antagonists, we conducted pharmacological reversal of the PPI deficits with the administration of raclopride. Besides a significant gene effect, a strong gene X raclopride effect on PPI was observed (gene X drug interaction p value, 0.0029). No significant effect was observed in the interactions between gene, raclopride and prepulse intensity. Therefore, we averaged the prepulse inhibition values across three different prepulse levels in both vehicle and drug groups. Post hoc analyses were conducted to compare the average PPI between vehicle and drug groups in three different genotypes. A significant improvement of PPI with raclopride was observed in both Sp4 heterozygous and homozygous mice (Figure 4a). Surprisingly, the administration of raclopride decreased PPI in wildtype mice, indicating possible drug effects on D2 autoreceptors in the regulation of dopamine release [36], [37]. The observed PPI improvement in both Sp4 heterozygous and homozygous mice could therefore be underestimated because of the PPI reduction caused by D2 autoreceptor inhibition.
###end p 52
###begin title 53
###xml 50 51 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Improvement of sensorimotor gating with dopamine D2 antagonist raclopride and carbamazepine in Sp4 mutant mice.
###end title 53
###begin p 54
###xml 694 697 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:10090">mice</span>
(a) A within subject design was used for the raclopride studies. The average PPI values across three different prepulse intensities were used for comparison. A significant PPI improvement was observed in both Sp4 heterozygous and homozygous mice after the administration of raclopride at the dosage of 3 mg/kg. The numbers of mice for the PPI studies were included in the parentheses after individual genotype (b) A between subject design was used for the carbamazepine studies. There were 7 mice in each group of WT-Veh and WT-CBZ mice, 14 mice in each group of Het-Veh and Het-CBZ mice, 7 mice in each group of Homo-Veh and Homo-CBZ mice. A significant PPI improvement was observed in female Sp4 heterozygous mice after the administration of carbamazepine at the dosage of 25 mg/kg. * p<0.05.
###end p 54
###begin p 55
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 314 323 314 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005196.s001">Figure S1</xref>
###xml 571 580 571 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005196.s001">Figure S1</xref>
###xml 880 889 880 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g004">Figure 4b</xref>
###xml 1094 1097 1094 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1212 1215 1212 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1273 1276 1273 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1342 1345 1342 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1593 1597 1593 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Messiha1">[38]</xref>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 874 878 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1098 1103 <span type="species:ncbi:10090">mouse</span>
###xml 1216 1220 <span type="species:ncbi:10090">mice</span>
###xml 1312 1316 <span type="species:ncbi:10090">mice</span>
###xml 1454 1458 <span type="species:ncbi:10090">mice</span>
Mood stabilizers have been used for the treatment of bipolar disorder. To study whether mood stabilizers can improve the PPI deficits, lithium chloride was administered acutely to reverse the PPI deficits in both Sp4 heterozygous and homozygous mice. Neither lithium nor gene X lithium effect on PPI was observed (Figure S1). In contrast, we observed that acute treatment with the mood stabilizer valproate improved PPI across all three different genotypes. However, the gene X valproate effect was not statistically significant due to the PPI increase in wildtype mice (Figure S1). Carbamazepine, an anticonvulsant used as a mood stabilizer, also increased PPI across all three genotypes at a dosage of 50 mg/kg. To minimize nonspecific drug effects, we decreased the dosage to 25 mg/kg. Surprisingly, we observed significant improvement of PPI only in female heterozygous mice (Figure 4b). Both wildtype and homozygous female mice did not respond to the administration of carbamazepine at this dosage. To confirm the observation, we examined the effects of carbamazepine on PPI in a separate Sp4 mouse cohort. We again observed that the reduced dosage of carbamazepine improved PPI only in female heterozygous Sp4 mice (data not shown). The differential response between Sp4 heterozygous and homozygous female mice may indicate the role of Sp4 function in the mediation of carbamazepine drug effect. The failure of PPI improvement in male heterozygous mice was unexpected, however, the gender effect was also observed in their differential startle response to carbamazepine (data not shown) [38].
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 57 60 57 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou1">[4]</xref>
###xml 179 182 179 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Zhou2">[5]</xref>
###xml 817 820 817 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 898 899 898 899 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 981 984 981 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 146 151 <span type="species:ncbi:9606">human</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 381 386 <span type="species:ncbi:9606">human</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
Our previous studies demonstrated a central role for the Sp4 gene in hippocampal development and modulation of a variety of behaviors relevant to human psychiatric disorders [4], [5]. The findings prompted us to examine whether human SP4 gene may associate with psychiatric disorders. After conducting genetic association studies, we observed a significant association between the human SP4 gene and bipolar disorder and schizophrenia in all three independent samples. It is especially striking that we saw association of the same alleles and haplotypes in both Caucasian and Chinese populations. Excessive dopamine transmission has been proposed in the pathophysiology of both bipolar disorder and schizophrenia; we therefore examined whether similar disruption of dopamine neurotransmission occurred in hypomorphic Sp4 mice. As expected, our pharmacological studies suggested that both dopamine D2 receptor antagonists and mood stabilizers partially reversed the PPI deficits in Sp4 mutant mice.
###end p 57
###begin p 58
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Cannon1">[39]</xref>
###xml 877 886 877 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g005">Figure 5a</xref>
###xml 1277 1286 1277 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g005">Figure 5b</xref>
###xml 1553 1557 1553 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Kertesz1">[40]</xref>
###xml 1559 1563 1559 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Grimson1">[41]</xref>
###xml 1636 1645 1636 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005196-g005">Figure 5b</xref>
###xml 138 143 <span type="species:ncbi:9606">Human</span>
###xml 672 680 <span type="species:ncbi:9606">patients</span>
###xml 788 793 <span type="species:ncbi:9606">human</span>
###xml 828 838 <span type="species:ncbi:9598">chimpanzee</span>
###xml 843 849 <span type="species:ncbi:9986">rabbit</span>
###xml 862 867 <span type="species:ncbi:10090">mouse</span>
###xml 872 875 <span type="species:ncbi:10116">rat</span>
###xml 1261 1266 <span type="species:ncbi:9606">human</span>
###xml 1620 1625 <span type="species:ncbi:10090">mouse</span>
###xml 1629 1634 <span type="species:ncbi:9606">human</span>
Psychiatric disorders are likely caused by multiple susceptibility genes, each with small effects in increasing the risk of illness [39]. Human population heterogeneity constitutes an enormous challenge; few susceptibility genes have so far been confirmed consistently for psychiatric disorders. We conducted two of our three association analyses in nuclear families, which are more robust to the effects of population substructure. The associations were further verified in the Chinese case-control sample, which complement the design of family studies. Significant overtransmission of the "A" allele from SNP7 (rs12673091) was observed in both bipolar and schizophrenia patients in all three independent samples. The "A" allele of SNP7 (rs12673091) was localized in the fifth intron of human SP4 gene and is conserved in both chimpanzee and rabbit, but not in mouse and rat (Figure 5a). SNP9 (rs3735440) also displayed significant association with bipolar disorder in both European Caucasian families and Chinese case-control samples. Interestingly, the overtransmitted "C" allele was localized in the putative binding site of microRNA (miR-145), which recognizes a seed sequence eight nucleotides downstream of the SNP9, in the 3' untranslated region of the human SP4 gene (Figure 5b). However, both "T/C" alleles cannot base-pair with the corresponding sequence of miR-145. It has been shown that unpaired sequence in the microRNA binding site could also play an important role in the regulation of interactions between microRNA and its target mRNA [40], [41]. In fact, the "T" allele of the SNP9 was conserved from mouse to human (Figure 5b). Therefore, the "C" allele of the SNP9 merits further studies as a potential functional mutation.
###end p 58
###begin title 59
Conservation of sequence polymorphism.
###end title 59
###begin p 60
Sequence conservation of the SNP 7 (a) and 9 (b) between different species.
###end p 60
###begin p 61
###xml 916 920 916 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Berrettini1">[42]</xref>
###xml 922 926 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Maier1">[43]</xref>
###xml 1331 1335 1331 1335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-BenShachar1">[30]</xref>
###xml 1639 1642 1639 1642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1846 1849 1846 1849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 2216 2220 2216 2220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005196-Gogos1">[44]</xref>
###xml 535 543 <span type="species:ncbi:9606">patients</span>
###xml 1101 1106 <span type="species:ncbi:9606">human</span>
###xml 1161 1166 <span type="species:ncbi:9606">human</span>
###xml 1322 1330 <span type="species:ncbi:9606">patients</span>
###xml 1633 1638 <span type="species:ncbi:10090">mouse</span>
###xml 1840 1845 <span type="species:ncbi:10090">mouse</span>
In addition to the consistency of single SNP associations in two different ethnic populations, we also observed that similar haplotypes significantly associated with bipolar disorder. In the Caucasian families, the haplotype (AGTTA) from SNP 6-10 (rs12668354, rs12673091, rs1018954, rs3735440, and rs11974306) was undertransmitted with a p value of 0.0004. Interestingly, a version of this haplotype (AGTT) from SNP 6-9 (rs12668354, rs12673091, rs1018954, rs3735440) was also undertransmitted with p value of 0.0399 in Chinese bipolar patients. Similarly, haplotypes CATCT and CATC were significantly overtransmitted in the Caucasian and Chinese populations, respectively. Taken together, these data provide strong support for the hypothesis that the SP4 gene functions as a susceptibility gene for bipolar disorder and possibly for schizophrenia as well, since the two disorders have overlapping genetic components [42], [43]. Unfortunately, the neuronal restrictive expression of SP4 gene prevented our further effort to study the association between these positive SNPs/haplotypes and the level of human SP4 gene expression. However, decreased expression of human SP1 gene, functionally redundant with its family member SP4 gene, was reported in the prefrontal cortex and striatum of postmortem brains of schizophrenia patients [30]. The reduced expression of SP1 family transcription factors may result in aberrant expression of many downstream target genes which contribute to the pathophysiology of schizophrenia and related disorders. Consistent with the reduced expression of SP1 gene in schizophrenia, reduced expression of mouse Sp4 gene resulted in both hippocampal abnormalities and deficient sensorimotor gating, two putative endophenotypes for schizophrenia and related psychiatric disorders. In this study, we found that the mouse Sp4 gene exhibits haploinsufficiency in the modulation of sensorimotor gating. This finding may be particularly relevant to consideration of SP4 as a candidate susceptibility gene for psychiatric disorders, as considerable evidence suggests that hypomorphic alleles, instead of loss of function, of multiple genes contribute to the pathogenesis of psychiatric disorders [44].
###end p 61
###begin p 62
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 228 229 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 293 296 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 417 420 417 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 848 851 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1078 1081 1078 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 1312 1315 1312 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 445 450 <span type="species:ncbi:9606">human</span>
###xml 658 662 <span type="species:ncbi:10090">mice</span>
###xml 739 743 <span type="species:ncbi:10090">mice</span>
###xml 852 856 <span type="species:ncbi:10090">mice</span>
###xml 1094 1098 <span type="species:ncbi:10090">mice</span>
###xml 1316 1320 <span type="species:ncbi:10090">mice</span>
###xml 1341 1346 <span type="species:ncbi:9606">human</span>
###xml 1432 1437 <span type="species:ncbi:10090">mouse</span>
Excessive dopamine neurotransmission has been demonstrated in both bipolar disorder and schizophrenia. Most clinically effective antipsychotics are dopamine D2 receptor antagonists. The administration of raclopride, a dopamine D2 antagonist, significantly improved sensorimotor gating in both Sp4 heterozygous and homozygous mice but not in wildtype mice, suggesting that dopamine neurotransmission may be altered in Sp4 mutant mice as it is in human psychiatric disorders. Considering significant genetic association between SP4 gene and bipolar disorder, we also examined the effects of different mood stabilizers on the reversal of PPI deficits in mutant mice. The mood stabilizer valproate improved PPI in both wildtype and Sp4 mutant mice. Acutely administrated carbamazepine also significantly reversed the PPI deficit in female heterozygous Sp4 mice. Although we did not observe effects of acutely administered lithium on PPI improvement, chronic administration of lithium may be necessary for the reversal of PPI deficits. Taken together, the pharmacological studies on Sp4 hypomorphic mice provided additional support for SP4 gene as a susceptibility gene for bipolar disorder and schizophrenia. In the future, it will be interesting to study whether similar pharmacogenetic interactions in hypomorphic Sp4 mice may be conserved in human. Such studies would be valuable for not only the cross-species validation of the Sp4 mouse model but also the development of gene-specific diagnosis and treatment.
###end p 62
###begin p 63
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 292 295 292 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sp4</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 462 467 <span type="species:ncbi:9606">human</span>
Our human genetic association studies provide direct evidence for the human SP4 gene as a susceptibility gene for both bipolar disorder and schizophrenia. However, the functional mutations in human SP4 remain to be studied. On the other hand, the elucidation of Sp4 molecular pathways in the Sp4 hypomorphic mouse model will provide novel insights in our understanding of neural circuitry in the regulation of sensorimotor gating and other behaviors relevant to human psychiatric disorders.
###end p 63
###begin title 64
Supporting Information
###end title 64
###begin p 65
(9.62 MB TIF)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
The authors thank Sorana Caldwell for technical assistance and Dr. Victoria Risbrough for statistical analysis.
###end p 67
###begin p 68
Data and biomaterials for a portion of the UCSD/UBC/UC families were collected by A. D. Sadovnick, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; R. A. Remick, Department of Psychiatry, St. Paul's Hospital, Vancouver, BC, Canada; and Paul E. Keck and Susan L. McElroy, Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio.
###end p 68
###begin p 69
###xml 468 472 <span type="species:ncbi:4530">Rice</span>
Data and biomaterials were also collected in four projects that participated in the National Institute of Mental Health (NIMH) Bipolar Disorder Genetics Initiative. From 1991-98, the Principal Investigators and Co-Investigators were: Indiana University, Indianapolis, IN, U01 MH46282, John Nurnberger, M.D., Ph.D., Marvin Miller, M.D., and Elizabeth Bowman, M.D.; Washington University, St. Louis, MO, U01 MH46280, Theodore Reich, M.D., Allison Goate, Ph.D., and John Rice, Ph.D.; Johns Hopkins University, Baltimore, MD U01 MH46274, J. Raymond DePaulo, Jr., M.D., Sylvia Simpson, M.D., MPH, and Colin Stine, Ph.D.; NIMH Intramural Research Program, Clinical Neurogenetics Branch, Bethesda, MD, Elliot Gershon, M.D., Diane Kazuba, B.A., and Elizabeth Maxwell, M.S.W.
###end p 69
###begin p 70
###xml 776 780 <span type="species:ncbi:4530">Rice</span>
Data and biomaterials were also collected as part of ten projects that participated in the National Institute of Mental Health (NIMH) Bipolar Disorder Genetics Initiative. From 1999-03, the Principal Investigators and Co-Investigators were: Indiana University, Indianapolis, IN, R01 MH59545, John Nurnberger, M.D., Ph.D., Marvin J. Miller, M.D., Elizabeth S. Bowman, M.D., N. Leela Rau, M.D., P. Ryan Moe, M.D., Nalini Samavedy, M.D., Rif El-Mallakh, M.D. (at University of Louisville), Husseini Manji, M.D. (at Wayne State University), Debra A. Glitz, M.D. (at Wayne State University), Eric T. Meyer, M.S., Carrie Smiley, R.N., Tatiana Foroud, Ph.D., Leah Flury, M.S., Danielle M. Dick, Ph.D., Howard Edenberg, Ph.D.; Washington University, St. Louis, MO, R01 MH059534, John Rice, Ph.D, Theodore Reich, M.D., Allison Goate, Ph.D., Laura Bierut, M.D.; Johns Hopkins University, Baltimore, MD, R01 MH59533, Melvin McInnis M.D., J. Raymond DePaulo, Jr., M.D., Dean F. MacKinnon, M.D., Francis M. Mondimore, M.D., James B. Potash, M.D., Peter P. Zandi, Ph.D, Dimitrios Avramopoulos, and Jennifer Payne; University of Pennsylvania, PA, R01 MH59553, Wade Berrettini M.D., Ph.D.; University of California at Irvine, CA, R01 MH60068, William Byerley M.D., and Mark Vawter M.D.; University of Iowa, IA, R01 MH059548, William Coryell M.D., and Raymond Crowe M.D., University of Chicago, IL, R01 MH59535, Elliot Gershon, M.D., Judith Badner, Ph.D., Francis McMahon, M.D., Chunyu Liu Ph.D., Alan Sanders M.D., Maria Caserta, Steven Dinwiddie M.D., Tu Nguyen, Donna Harakal; University of California at San Diego, CA, R01 MH59567, John Kelsoe, M.D., Rebecca McKinney, B.A.; Rush University, IL, R01 MH059556, William Scheftner M.D., Howard M. Kravitz, D.O., M.P.H., Diana Marta, B.S., Annette Vaughn-Brown, MSN, RN, and Laurie Bederow, MA; NIMH Intramural Research Program, Bethesda, MD, 1Z01MH002810-01, Francis J. McMahon, M.D., Layla Kassem, Ph.D, Sevilla Detera-Wadleigh, Ph.D, Lisa Austin, Ph.D, Dennis L. Murphy, M.D.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
###xml 121 126 <span type="species:ncbi:9606">human</span>
CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome.
###end article-title 72
###begin article-title 73
The Sp-family of transcription factors.
###end article-title 73
###begin article-title 74
###xml 93 99 <span type="species:ncbi:10090">murine</span>
Sp4, a member of the Sp1-family of zinc finger transcription factors, is required for normal murine growth, viability, and male fertility.
###end article-title 74
###begin article-title 75
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization.
###end article-title 75
###begin article-title 76
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Impaired postnatal development of hippocampal dentate gyrus in Sp4 null mutant mice.
###end article-title 76
###begin article-title 77
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 66 73 <span type="species:ncbi:9606">patient</span>
Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.
###end article-title 77
###begin article-title 78
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.
###end article-title 78
###begin article-title 79
Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22.
###end article-title 79
###begin article-title 80
Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24.
###end article-title 80
###begin article-title 81
Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk.
###end article-title 81
###begin article-title 82
Genomewide survey of panic disorder.
###end article-title 82
###begin article-title 83
Results of a genome-wide genetic screen for panic disorder.
###end article-title 83
###begin article-title 84
A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q.
###end article-title 84
###begin article-title 85
A genomic screen of autism: evidence for a multilocus etiology.
###end article-title 85
###begin article-title 86
De novo partial duplication of chromosome 7p in a male with autistic disorder.
###end article-title 86
###begin article-title 87
Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders.
###end article-title 87
###begin article-title 88
Genetics of autism: complex aetiology for a heterogeneous disorder.
###end article-title 88
###begin article-title 89
Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q.
###end article-title 89
###begin article-title 90
Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q.
###end article-title 90
###begin article-title 91
Convergent functional genomics of genome-wide association data for bipolar disorder: Comprehensive identification of candidate genes, pathways and mechanisms.
###end article-title 91
###begin article-title 92
Genomic survey of bipolar illness in the NIMH genetics initiative pedigrees: a preliminary report.
###end article-title 92
###begin article-title 93
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.
###end article-title 93
###begin article-title 94
A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22.
###end article-title 94
###begin article-title 95
Haploview: analysis and visualization of LD and haplotype maps.
###end article-title 95
###begin article-title 96
Haplotype reconstruction from genotype data using Imperfect Phylogeny.
###end article-title 96
###begin article-title 97
Parental phenotypes in family-based association analysis.
###end article-title 97
###begin article-title 98
Pedigree disequilibrium tests for multilocus haplotypes.
###end article-title 98
###begin article-title 99
Distribution of recombination crossovers and the origin of haplotype blocks: the interplay of population history, recombination, and mutation.
###end article-title 99
###begin article-title 100
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data.
###end article-title 100
###begin article-title 101
Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2.
###end article-title 101
###begin article-title 102
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania.
###end article-title 102
###begin article-title 103
###xml 85 93 <span type="species:ncbi:9606">Patients</span>
Evidence of Disrupted Prepulse Inhibition in Unaffected Siblings of Bipolar Disorder Patients.
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse genetic models for prepulse inhibition: an early review.
###end article-title 104
###begin article-title 105
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis-a longitudinal study.
###end article-title 105
###begin article-title 106
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function.
###end article-title 106
###begin article-title 107
Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study.
###end article-title 107
###begin article-title 108
Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors.
###end article-title 108
###begin article-title 109
Carbamazepine and ethanol elicited responses in rodents.
###end article-title 109
###begin article-title 110
Endophenotypes in the genetic analyses of mental disorders.
###end article-title 110
###begin article-title 111
The role of site accessibility in microRNA target recognition.
###end article-title 111
###begin article-title 112
MicroRNA targeting specificity in mammals: determinants beyond seed pairing.
###end article-title 112
###begin article-title 113
Bipolar disorder and schizophrenia: not so distant relatives?
###end article-title 113
###begin article-title 114
Schizophrenia and bipolar disorder: differences and overlaps.
###end article-title 114
###begin article-title 115
###xml 29 33 <span type="species:ncbi:10090">mice</span>
"Targeting" schizophrenia in mice.
###end article-title 115
###begin p 116
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: I, John Kelsoe, am co-founder, Chief Scientific Officer, and member of the board of directors for the company Psynomics, Inc., which does DNA testing. I advise the company in the selection of genes for diagnostic and pharmacogenetic testing. I also advise them regarding the interpretation of these tests and the clinical and ethical issues around implementation of the testing.
###end p 116
###begin p 117
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: NIH Grant#MH073991; NIH Grant#MH47612; NIH Grant#MH59567; NIH Grant#MH68503; NARSAD ; Veterans Affairs VISN 22 Mental Illness Research, Education and Clinical Center . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. M.A. Geyer holds an equity interest in San Diego Instruments. J. Kelsoe is a founder and holds equity in Psynomics, Inc. The terms of these arrangements have been reviewed and approved by University of California, San Diego in accordance with its conflict of interest policies.
###end p 117

